1.The neurophysiological mechanisms of exercise-induced improvements in cognitive function.
Jian-Xiu LIU ; Bai-Le WU ; Di-Zhi WANG ; Xing-Tian LI ; Yan-Wei YOU ; Lei-Zi MIN ; Xin-Dong MA
Acta Physiologica Sinica 2025;77(3):504-522
The neurophysiological mechanisms by which exercise improves cognitive function have not been fully elucidated. A comprehensive and systematic review of current domestic and international neurophysiological evidence on exercise improving cognitive function was conducted from multiple perspectives. At the molecular level, exercise promotes nerve cell regeneration and synaptogenesis and maintains cellular development and homeostasis through the modulation of a variety of neurotrophic factors, receptor activity, neuropeptides, and monoamine neurotransmitters, and by decreasing the levels of inflammatory factors and other modulators of neuroplasticity. At the cellular level, exercise enhances neural activation and control and improves brain structure through nerve regeneration, synaptogenesis, improved glial cell function and angiogenesis. At the structural level of the brain, exercise promotes cognitive function by affecting white and gray matter volumes, neural activation and brain region connectivity, as well as increasing cerebral blood flow. This review elucidates how exercise improves the internal environment at the molecular level, promotes cell regeneration and functional differentiation, and enhances the brain structure and neural efficiency. It provides a comprehensive, multi-dimensional explanation of the neurophysiological mechanisms through which exercise promotes cognitive function.
Animals
;
Humans
;
Brain/physiology*
;
Cognition/physiology*
;
Exercise/physiology*
;
Nerve Regeneration/physiology*
;
Neuronal Plasticity/physiology*
2.Effect of TBL1XR1 Mutation on Cell Biological Characteristics of Diffuse Large B-Cell Lymphoma.
Hong-Ming FAN ; Le-Min HONG ; Chun-Qun HUANG ; Jin-Feng LU ; Hong-Hui XU ; Jie CHEN ; Hong-Ming HUANG ; Xin-Feng WANG ; Dan GUO
Journal of Experimental Hematology 2025;33(2):423-430
OBJECTIVE:
To investigate the effect of TBL1XR1 mutation on cell biological characteristics of diffuse large B-cell lymphoma (DLBCL).
METHODS:
The TBL1XR1 overexpression vector was constructed and DNA sequencing was performed to determine the mutation status. The effect of TBL1XR1 mutation on apoptosis of DLBCL cell line was detected by flow cytometry and TUNEL fluorescence assay; CCK-8 assay was used to detect the effect of TBL1XR1 mutation on cell proliferation; Transwell assay was used to detect the effect of TBL1XR1 mutation on cell migration and invasion; Western blot was used to detect the effect of TBL1XR1 mutation on the expression level of epithelial-mesenchymal transition (EMT) related proteins.
RESULTS:
The TBL1XR1 overexpression plasmid was successfully constructed. The in vitro experimental results showed that TBL1XR1 mutation had no significant effect on apoptosis of DLBCL cells. Compared with the control group, TBL1XR1 mutation enhanced cell proliferation, migration and invasion of DLBCL cells. TBL1XR1 gene mutation significantly increased the expression of N-cadherin protein, while the expression of E-cadherin protein decreased.
CONCLUSION
TBL1XR1 mutation plays a role in promoting tumor cell proliferation, migration and invasion in DLBCL. TBL1XR1 could be considered as a potential target for DLBCL therapy in future research.
Humans
;
Lymphoma, Large B-Cell, Diffuse/pathology*
;
Cell Proliferation
;
Mutation
;
Receptors, Cytoplasmic and Nuclear/genetics*
;
Apoptosis
;
Cell Line, Tumor
;
Epithelial-Mesenchymal Transition
;
Cell Movement
;
Repressor Proteins/genetics*
;
Nuclear Proteins/genetics*
;
Cadherins/metabolism*
3.A Clinical Study of Children with SIL-TAL1-Positive Acute T-Lymphoblastic Leukemia.
Yu-Juan XUE ; Yu WANG ; Le-Ping ZHANG ; Ai-Dong LU ; Yue-Ping JIA ; Hui-Min ZENG
Journal of Experimental Hematology 2025;33(5):1262-1268
OBJECTIVE:
To explore the clinical characteristics and prognosis of children with SIL-TAL1-positive T-cell acute lymphoblastic leukemia ( SIL-TAL1+ T-ALL).
METHODS:
The clinical data of 110 children with newly diagnosed T-ALL admitted to the pediatric department of our hospital from January 2010 to December 2018 were reviewed to compare the clinical characteristics, treatment response and prognosis between SIL-TAL1+ group and SIL-TAL1-group.
RESULTS:
Among the 110 children with T-ALL, 25 cases (22.7%) were in the SIL-TAL1+ group and 85 cases (77.3%) in the SIL-TAL1- group. The white blood cell (WBC) count in the SIL-TAL1+ group was significantly higher than that in the SIL-TAL1- group (P < 0.05), while the other clinical characteristics and treatment response were not significantly different between the two groups. The 5-year overall survival (OS) rates of SIL-TAL1+ group and SIL-TAL1- group were 80.0% and 75.5%, and 5-year disease-free survival (DFS) rates were 76.0% and 72.9%, respectively. There were no significant differences in OS rate and DFS rate between the two groups ( P >0.05). In children aged < 10 years, the 5-year OS rate of SIL-TAL1+ group and SIL-TAL1- group was 100% and 75.1%, respectively, and the difference between the two groups was statistically significant (P < 0.05).
CONCLUSION
Although the WBC level is significantly higher in children with SIL-TAL1+ T-ALL than that in those with SIL-TAL1- T-ALL, the treatment efficacy is similar between the two groups. In children aged < 10 years, the longterm survival rate is superior in the SIL-TAL1+ group.
Humans
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis*
;
Prognosis
;
Child
;
Male
;
Female
;
Survival Rate
;
T-Cell Acute Lymphocytic Leukemia Protein 1
;
Child, Preschool
;
Oncogene Proteins, Fusion
;
Leukocyte Count
4.Berg Balance Scale score is a valuable predictor of all-cause mortality among acute decompensated heart failure patients.
Yu-Xuan FAN ; Jing-Jing CHENG ; Zhi-Qing FAN ; Jing-Jin LIU ; Wen-Juan XIU ; Meng-Yi ZHAN ; Lin LUO ; Guang-He LI ; Le-Min WANG ; Yu-Qin SHEN
Journal of Geriatric Cardiology 2025;22(6):555-562
OBJECTIVE:
To investigate possible associations between physical function assessment scales, such as Short Physical Performance Battery (SPPB) and Berg Balance Scale (BBS), with all-cause mortality in acute decompensated heart failure (ADHF) patients.
METHODS:
A total of 108 ADHF patients were analyzed from October 2020 to October 2022, and followed up to May 2023. The association between baseline clinical characteristics and all-cause mortality was analyzed by univariate Cox regression analysis, while for SPPB and BBS, univariate Cox regression analysis was followed by receiver operating characteristic curves, in which the area under the curve represented their predictive accuracy for all-cause mortality. Incremental predictive values for both physical function assessments were measured by calculating net reclassification index and integrated discrimination improvement scores. Optimal cut-off value for BBS was then identified using restricted cubic spline plots, and survival differences below and above that cut-off were compared using Kaplan-Meier survival curves and the log-rank test. The clinical utility of BBS was measured using decision curve analysis.
RESULTS:
For baseline characteristics, age, female, blood urea nitrogen, as well as statins, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or angiotensin receptor-neprilysin inhibitors, were predictive for all-cause mortality for ADHF patients. With respect to SPPB and BBS, higher scores were associated with lower all-cause mortality rates for both assessments; similar area under the curves were measured for both (0.774 for SPPB and 0.776 for BBS). Furthermore, BBS ≤ 36.5 was associated with significantly higher mortality, which was still applicable even adjusting for confounding factors; BBS was also found to have great clinical utility under decision curve analysis.
CONCLUSIONS
BBS or SPPB could be used as tools to assess physical function in ageing ADHF patients, as well as prognosticate on all-cause mortality. Moreover, prioritizing the improvement of balance capabilities of ADHF patients in cardiac rehabilitation regimens could aid in lowering mortality risk.
5.Protective effect and mechanism of farrerol on acute lung injury induced by lipopolysaccharide in mice
Yanyan WU ; Yufei WANG ; Min CHEN ; Xuanping ZHANG ; Le LUO
Chinese Journal of Pharmacology and Toxicology 2025;39(1):36-45
OBJECTIVE To investigate the protective effect of farrerol against lipopolysaccharide(LPS)induced acute lung injury(ALI)in mice and the mechanisms.METHODS ①ICR rats were randomly divided into the normal control group,model group and model+farrerol group,with 6 rats in each.The normal control group and model group were given an equal amount of normal saline intragaically for 4 d.The model+farrerol group was given 20 and 40 mg·kg-1 intragaically for 4 d,while the normal control group was given an equal amount of normal saline intragaically on the 5th day.The model group and model+farrerol group were injected with 3 mg·kg-1 LPS solution for 24 h to construct an animal model of ALI.② Mouse alveolar macrophages(MH-S)were cultured and randomly divided into the cell control group,model group and model+farrerol group.Cell control group(conventional culture for 24 h),model group(100 μg·L-1 LPS combined with 40 μg·L-1 IFN-γ co-incubation for 24 h),model+farrerol group(5,10 and 20 μmol·L-1 farrerol pretreatment of MH-S cells for 24 h,and then 100 μg·L-1 LPS combined with 40 μg·L-1 IFN-γ co-incubation for 24 h),an inflammatory cell model was established in vitro.HE was used to observe the pathological changes of the lungs.The wet-dry weight ratio(W/D)was used to assess pulmonary edema while Evans blue dye(EBD)was used to detect pulmonary vascular permea-bility.The activity of myeloperoxidase(MPO)was detected by colorimetry.The number of white blood cells in BALF was counted with a blood cell counting plate.Cell proliferation assay(CCK-8)was used to determine the cell viability.The levels of interleukin-1β(IL-1β),tumor necrosis factor α(TNF-α),IL-6 and IL-10 in lung tissue,bronchoalveolar lavage fluid(BALF)and cell supernatants were detected via enzyme-linked immunosorbent assay(ELISA).The protein levels of inducable nitric oxide synthase(iNOS),arginase 1(ARG1),phosphorylated NF-κB p65,NOD-like receptor protein 3(NLRP3),cysteinyl aspartate specific proteinase1(caspase1)and gasdermin family member(GSDMD-N terminal)in lung tissue and MH-S cells were detected with Western blot.RESULTS ① Compared with the normal control group,the histopathological changes,Injury score,W/D ratio,pulmonary vascular permeability,MPO content,leukocyte count,pro-inflammatory factor IL-1β,TNF-α,IL-6 levels,iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSDMD-N-terminal protein expression in lung tissues were signifi-cantly increased in the model group(P<0.05,P<0.01)while the expression levels of anti-inflammatory factors IL-10 and ARG1 were decreased(P<0.05,P<0.01).Compared with the model group,the Injury score,W/D ratio,pulmonary vascular permeability,leukocyte number,MPO content,proinflammatory factor content and iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSDMD-N-terminal protein levels were significantly decreased in the model+farrerol group(P<0.05,P<0.01)while the levels of anti-inflammatory factor IL-10 and ARG1 protein were increased(P<0.05,P<0.01).② The results of in vitro experiments showed that compared with the cell control group,the contents of IL-1β,TNF-α and IL-6 and the expression levels of iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSD-MD-N-terminal protein were increased(P<0.05,P<0.01),and that the content of anti-inflammatory factor IL-10 and expression level of ARG1 protein were decreased(P<0.01).Compared with the model group,the content of proinflammatory factor and the expressions of iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSDMD-N protein in the model+farrerol group were significantly decreased(P<0.05,P<0.01)while the expression levels of IL-10 and ARG1 protein were increased(P<0.05,P<0.01).CONCLUSION Farrerol can alleviate acute lung injury induced by LPS in mice,possibly by inhibiting the phosphorylation of NF-κB p65 and activation of NLRP3 inflammatome,alleviating pyroptosis of cells and regulating macrophage polarization.
6.Causal relationship between gut microbiota and rheumatoid arthritis:data analysis in European populations based on GWAS data
Tao WANG ; Shunpu WANG ; Youjiang MIN ; Min WANG ; Le LI ; Chen ZHANG ; Weiping XIAO
Chinese Journal of Tissue Engineering Research 2025;29(35):7663-7668
BACKGROUND:Studies have shown that gut microbiota may affect the progression of rheumatoid arthritis.However,the causal relationship between the two is unknown.Mendelian randomization analysis of the two using published Genome Wide Association Study(GWAS)data can explore the causal relationship between gut microbiota and rheumatoid arthritis,helping to develop targeted microbial therapies and provide methods and strategies for the prevention and treatment of rheumatoid arthritis.OBJECTIVE:To explore the potential causal relationship between gut microbiota and rheumatoid arthritis using two-sample two-way Mendelian randomization method.METHODS:Gut microbiota GWAS data from the MiBio-Gen consortium and rheumatoid arthritis GWAS data from the IEU Open GWAS database(a large gene-phenotype association database developed at the MRC Integrative Epidemiology Unit(IEU)at the University of Bristol,UK)were used.Inverse variance weighting was used as the main analysis method,and MR-Egger regression method,weighted median method,weighted model and simple model method were used as supplements to study the causal relationship between gut microbiota and rheumatoid arthritis.Heterogeneity was assessed using Cochran's Q test,horizontal pleiotropy was assessed using MR-PRESSO and MR-Egger intercept tests,robustness of results was tested using leave-one method,and reverse Mendelian randomization analysis was used to assess the presence or absence of reverse causality.RESULTS AND CONCLUSION:(1)There was a causal relationship between five kinds of enteric bacteria and rheumatoid arthritis.Ruminococcus gauvreauii group(β=0.262,odds ratio[OR]=1.300,P=0.013)and Butyricimonas(β=0.001,OR=1.001,P=0.014)increased the risk of rheumatoid arthritis,while Anaerostipes(β=-0.225,OR=0.798,P=0.025),Lachnospiraceae-UCG010(β=-0.177,OR=0.838,P=0.026)and Oxalobacter(β=-0.171,OR=0.843,P=0.001)reduced the risk of rheumatoid arthritis.Sensitivity analyses showed no significant heterogeneity or horizontal pleiotropy(all P>0.05),and leave-one-out testing confirmed the robustness of the results,while the addition of the remaining four methods other than the inverse variance weighting method further validated the reliability and stability of the results.(2)Reverse Mendelian randomization analysis did not find a causal association between rheumatoid arthritis and the five kinds of enteric bacteria identified by Mendelian randomization analysis.These findings indicate that Ruminococcus gauvreauii group and Butyricimonas may be the risk factors of rheumatoid arthritis,while Anaerostipes,Lachnospiraceae-UCG010 and Oxalobacter may be the protective factors of rheumatoid arthritis.Gut microbiota may play an important role in the pathogenesis of rheumatoid arthritis,and provide new biomarkers for the prevention and treatment of rheumatoid arthritis.In addition,for the field of biomedical research in China,we can learn from international experience and gradually establish and improve a multi-center large-scale genetic database,so as to deeply explore the relationship between gut microbiota and disease risk,and promote the development of precision medicine and personalized treatment in China.
7.Protective effect and mechanism of farrerol on acute lung injury induced by lipopolysaccharide in mice
Yanyan WU ; Yufei WANG ; Min CHEN ; Xuanping ZHANG ; Le LUO
Chinese Journal of Pharmacology and Toxicology 2025;39(1):36-45
OBJECTIVE To investigate the protective effect of farrerol against lipopolysaccharide(LPS)induced acute lung injury(ALI)in mice and the mechanisms.METHODS ①ICR rats were randomly divided into the normal control group,model group and model+farrerol group,with 6 rats in each.The normal control group and model group were given an equal amount of normal saline intragaically for 4 d.The model+farrerol group was given 20 and 40 mg·kg-1 intragaically for 4 d,while the normal control group was given an equal amount of normal saline intragaically on the 5th day.The model group and model+farrerol group were injected with 3 mg·kg-1 LPS solution for 24 h to construct an animal model of ALI.② Mouse alveolar macrophages(MH-S)were cultured and randomly divided into the cell control group,model group and model+farrerol group.Cell control group(conventional culture for 24 h),model group(100 μg·L-1 LPS combined with 40 μg·L-1 IFN-γ co-incubation for 24 h),model+farrerol group(5,10 and 20 μmol·L-1 farrerol pretreatment of MH-S cells for 24 h,and then 100 μg·L-1 LPS combined with 40 μg·L-1 IFN-γ co-incubation for 24 h),an inflammatory cell model was established in vitro.HE was used to observe the pathological changes of the lungs.The wet-dry weight ratio(W/D)was used to assess pulmonary edema while Evans blue dye(EBD)was used to detect pulmonary vascular permea-bility.The activity of myeloperoxidase(MPO)was detected by colorimetry.The number of white blood cells in BALF was counted with a blood cell counting plate.Cell proliferation assay(CCK-8)was used to determine the cell viability.The levels of interleukin-1β(IL-1β),tumor necrosis factor α(TNF-α),IL-6 and IL-10 in lung tissue,bronchoalveolar lavage fluid(BALF)and cell supernatants were detected via enzyme-linked immunosorbent assay(ELISA).The protein levels of inducable nitric oxide synthase(iNOS),arginase 1(ARG1),phosphorylated NF-κB p65,NOD-like receptor protein 3(NLRP3),cysteinyl aspartate specific proteinase1(caspase1)and gasdermin family member(GSDMD-N terminal)in lung tissue and MH-S cells were detected with Western blot.RESULTS ① Compared with the normal control group,the histopathological changes,Injury score,W/D ratio,pulmonary vascular permeability,MPO content,leukocyte count,pro-inflammatory factor IL-1β,TNF-α,IL-6 levels,iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSDMD-N-terminal protein expression in lung tissues were signifi-cantly increased in the model group(P<0.05,P<0.01)while the expression levels of anti-inflammatory factors IL-10 and ARG1 were decreased(P<0.05,P<0.01).Compared with the model group,the Injury score,W/D ratio,pulmonary vascular permeability,leukocyte number,MPO content,proinflammatory factor content and iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSDMD-N-terminal protein levels were significantly decreased in the model+farrerol group(P<0.05,P<0.01)while the levels of anti-inflammatory factor IL-10 and ARG1 protein were increased(P<0.05,P<0.01).② The results of in vitro experiments showed that compared with the cell control group,the contents of IL-1β,TNF-α and IL-6 and the expression levels of iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSD-MD-N-terminal protein were increased(P<0.05,P<0.01),and that the content of anti-inflammatory factor IL-10 and expression level of ARG1 protein were decreased(P<0.01).Compared with the model group,the content of proinflammatory factor and the expressions of iNOS,phosphorylated NF-κB p65,NLRP3,caspase1 and GSDMD-N protein in the model+farrerol group were significantly decreased(P<0.05,P<0.01)while the expression levels of IL-10 and ARG1 protein were increased(P<0.05,P<0.01).CONCLUSION Farrerol can alleviate acute lung injury induced by LPS in mice,possibly by inhibiting the phosphorylation of NF-κB p65 and activation of NLRP3 inflammatome,alleviating pyroptosis of cells and regulating macrophage polarization.
8.Causal relationship between gut microbiota and rheumatoid arthritis:data analysis in European populations based on GWAS data
Tao WANG ; Shunpu WANG ; Youjiang MIN ; Min WANG ; Le LI ; Chen ZHANG ; Weiping XIAO
Chinese Journal of Tissue Engineering Research 2025;29(35):7663-7668
BACKGROUND:Studies have shown that gut microbiota may affect the progression of rheumatoid arthritis.However,the causal relationship between the two is unknown.Mendelian randomization analysis of the two using published Genome Wide Association Study(GWAS)data can explore the causal relationship between gut microbiota and rheumatoid arthritis,helping to develop targeted microbial therapies and provide methods and strategies for the prevention and treatment of rheumatoid arthritis.OBJECTIVE:To explore the potential causal relationship between gut microbiota and rheumatoid arthritis using two-sample two-way Mendelian randomization method.METHODS:Gut microbiota GWAS data from the MiBio-Gen consortium and rheumatoid arthritis GWAS data from the IEU Open GWAS database(a large gene-phenotype association database developed at the MRC Integrative Epidemiology Unit(IEU)at the University of Bristol,UK)were used.Inverse variance weighting was used as the main analysis method,and MR-Egger regression method,weighted median method,weighted model and simple model method were used as supplements to study the causal relationship between gut microbiota and rheumatoid arthritis.Heterogeneity was assessed using Cochran's Q test,horizontal pleiotropy was assessed using MR-PRESSO and MR-Egger intercept tests,robustness of results was tested using leave-one method,and reverse Mendelian randomization analysis was used to assess the presence or absence of reverse causality.RESULTS AND CONCLUSION:(1)There was a causal relationship between five kinds of enteric bacteria and rheumatoid arthritis.Ruminococcus gauvreauii group(β=0.262,odds ratio[OR]=1.300,P=0.013)and Butyricimonas(β=0.001,OR=1.001,P=0.014)increased the risk of rheumatoid arthritis,while Anaerostipes(β=-0.225,OR=0.798,P=0.025),Lachnospiraceae-UCG010(β=-0.177,OR=0.838,P=0.026)and Oxalobacter(β=-0.171,OR=0.843,P=0.001)reduced the risk of rheumatoid arthritis.Sensitivity analyses showed no significant heterogeneity or horizontal pleiotropy(all P>0.05),and leave-one-out testing confirmed the robustness of the results,while the addition of the remaining four methods other than the inverse variance weighting method further validated the reliability and stability of the results.(2)Reverse Mendelian randomization analysis did not find a causal association between rheumatoid arthritis and the five kinds of enteric bacteria identified by Mendelian randomization analysis.These findings indicate that Ruminococcus gauvreauii group and Butyricimonas may be the risk factors of rheumatoid arthritis,while Anaerostipes,Lachnospiraceae-UCG010 and Oxalobacter may be the protective factors of rheumatoid arthritis.Gut microbiota may play an important role in the pathogenesis of rheumatoid arthritis,and provide new biomarkers for the prevention and treatment of rheumatoid arthritis.In addition,for the field of biomedical research in China,we can learn from international experience and gradually establish and improve a multi-center large-scale genetic database,so as to deeply explore the relationship between gut microbiota and disease risk,and promote the development of precision medicine and personalized treatment in China.
9.Immediate metatarsal lengthening for congenital brachymetatarsia.
Bo-Lai WU ; Xiao-Jun WANG ; Zhi-Min MA ; Le-Bin WU ; Zi-Hao LU
China Journal of Orthopaedics and Traumatology 2024;37(12):1208-1212
OBJECTIVE:
To explore clinical efficacy of congenital brachymetatarsia with immediate metatarsal lengthening.
METHODS:
From March 2015 to December 2020, 7 patients with brachymetatarsia were treated, including 6 females and 1 male;aged range from 18 to 30 years old;there were 5 patients with metatarsal microsomia on one foot, 2 patients with metatarsal microsomia on the first and fourth right foot, and immediate extension of metatarsal microsomia on the first and fourth right foot;two patients were short metatarsal bones of both feet. The length of short metatarsal bone, length of normal metatarsal bone, distance of short metatarsal bone and healing of bone graft were observed before and 12 months after operation. American Orthopaedic Foot and Ankle Society (AOFAS) scores were used to evaluate clinical efficacy and observe complications.
RESULTS:
Seven patients were followed up for 12 to 24 months. All metatarsal bones were extended to satisfactory length and bone graft were healed completely. Metatarsal length and shortening distance were improved from 3.55 to 5.90 cm and 0.77 to 1.46 cm before operation to 4.31 to 6.87 cm and 0.04 to 0.57 cm at 12 months after operation. Postoperative X-ray of the affected foot at 12 months showed bone healing was achieved between metatarsal bone and bone graft in 7 patients, and the parabolic shape of the distal metatarsal bone recovered after operation. AOFAS scores improved from 40 to 70 before operation to 88 to 95 points at 12 months after operation, and 6 patients were excellent and 1 good.
CONCLUSION
Immediate extension of metatarsal bone for congenital brachymetatarsia, the transplanted bone grew well during the process of bone grafting healing, the occurrence of bone nonunion was reduced, the short metatarsal bone was restored to a satisfactory length, and the toe function restored well.
Humans
;
Female
;
Male
;
Metatarsal Bones/abnormalities*
;
Adult
;
Adolescent
;
Young Adult
;
Bone Lengthening/methods*
;
Foot Deformities, Congenital/surgery*
10.Traditional Use, Phytochemistry, Pharmacology, Toxicology and Clinical Applications of Persicae Semen: A Review.
Yu-Quan LIU ; Hui-Li WU ; Zhi-Qiang ZHANG ; Wen-le WANG ; Guo-Qing HAN ; Chun-Hong ZHANG ; Xin-Liang LYU ; Chun-Jie MA ; Min-Hui LI
Chinese journal of integrative medicine 2024;30(12):1137-1147
Persicae Semen (Taoren), the seed of mature peaches consumed as both food and medicine, is native to the temperate regions of China, distributed in the provinces of North and East China, and currently cultivated worldwide. The primary components of Persicae Semen include volatile oil, protein, amino acids, amygdalin, and prunasin, all of which have pharmacological properties, such as anti-inflammatory, antioxidant, and immune regulatory effects, and are clinically used in the treatment of gynecological, cardiovascular, cerebrovascular, orthopedic, and digestive system diseases. This review provides a comprehensive perspective on the resource status, ethnopharmacology, phytochemistry, pharmacology, and toxicology, as well as the trend of Persicae Semen patent, global distribution, and clinical applications. This review will help facilitate the development and utilization of Persicae Semen in clinical settings.
Humans
;
Phytochemicals/chemistry*
;
Animals
;
Drugs, Chinese Herbal/therapeutic use*
;
Medicine, Chinese Traditional/methods*
;
Medicine, Traditional/methods*

Result Analysis
Print
Save
E-mail